Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1960 1
1963 2
1964 2
1965 1
1966 1
1967 4
1968 5
1969 2
1970 5
1971 1
1972 1
1973 3
1974 3
1975 2
1976 2
1977 1
1978 2
1979 1
1980 3
1981 4
1982 2
1983 9
1984 6
1985 3
1986 4
1987 5
1988 5
1989 12
1990 8
1991 12
1992 5
1993 9
1994 8
1995 12
1996 11
1997 13
1998 18
1999 28
2000 34
2001 33
2002 41
2003 64
2004 112
2005 114
2006 117
2007 121
2008 145
2009 159
2010 164
2011 201
2012 187
2013 242
2014 208
2015 238
2016 230
2017 251
2018 220
2019 254
2020 245
2021 45
Text availability
Article attribute
Article type
Publication date

Search Results

3,199 results
Results by year
Filters applied: . Clear all
Page 1
Altered human oligodendrocyte heterogeneity in multiple sclerosis.
Jäkel S, Agirre E, Mendanha Falcão A, van Bruggen D, Lee KW, Knuesel I, Malhotra D, Ffrench-Constant C, Williams A, Castelo-Branco G. Jäkel S, et al. Among authors: lee kw. Nature. 2019 Feb;566(7745):543-547. doi: 10.1038/s41586-019-0903-2. Epub 2019 Jan 23. Nature. 2019. PMID: 30747918 Free PMC article.
Efficacy and Safety of Pembrolizumab or Pembrolizumab Plus Chemotherapy vs Chemotherapy Alone for Patients With First-line, Advanced Gastric Cancer: The KEYNOTE-062 Phase 3 Randomized Clinical Trial.
Shitara K, Van Cutsem E, Bang YJ, Fuchs C, Wyrwicz L, Lee KW, Kudaba I, Garrido M, Chung HC, Lee J, Castro HR, Mansoor W, Braghiroli MI, Karaseva N, Caglevic C, Villanueva L, Goekkurt E, Satake H, Enzinger P, Alsina M, Benson A, Chao J, Ko AH, Wainberg ZA, Kher U, Shah S, Kang SP, Tabernero J. Shitara K, et al. Among authors: lee kw. JAMA Oncol. 2020 Oct 1;6(10):1571-1580. doi: 10.1001/jamaoncol.2020.3370. JAMA Oncol. 2020. PMID: 32880601 Clinical Trial.
Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4).
Boku N, Ryu MH, Kato K, Chung HC, Minashi K, Lee KW, Cho H, Kang WK, Komatsu Y, Tsuda M, Yamaguchi K, Hara H, Fumita S, Azuma M, Chen LT, Kang YK. Boku N, et al. Among authors: lee kw. Ann Oncol. 2019 Feb 1;30(2):250-258. doi: 10.1093/annonc/mdy540. Ann Oncol. 2019. PMID: 30566590 Free PMC article. Clinical Trial.
Genetic diversity of tumors with mismatch repair deficiency influences anti-PD-1 immunotherapy response.
Mandal R, Samstein RM, Lee KW, Havel JJ, Wang H, Krishna C, Sabio EY, Makarov V, Kuo F, Blecua P, Ramaswamy AT, Durham JN, Bartlett B, Ma X, Srivastava R, Middha S, Zehir A, Hechtman JF, Morris LG, Weinhold N, Riaz N, Le DT, Diaz LA Jr, Chan TA. Mandal R, et al. Among authors: lee kw. Science. 2019 May 3;364(6439):485-491. doi: 10.1126/science.aau0447. Science. 2019. PMID: 31048490 Free PMC article.
A phase 3 study of nivolumab in previously treated advanced gastric or gastroesophageal junction cancer (ATTRACTION-2): 2-year update data.
Chen LT, Satoh T, Ryu MH, Chao Y, Kato K, Chung HC, Chen JS, Muro K, Kang WK, Yeh KH, Yoshikawa T, Oh SC, Bai LY, Tamura T, Lee KW, Hamamoto Y, Kim JG, Chin K, Oh DY, Minashi K, Cho JY, Tsuda M, Sameshima H, Kang YK, Boku N. Chen LT, et al. Among authors: lee kw. Gastric Cancer. 2020 May;23(3):510-519. doi: 10.1007/s10120-019-01034-7. Epub 2019 Dec 20. Gastric Cancer. 2020. PMID: 31863227 Free PMC article.
2019 Clinical Practice Guidelines for Type 2 Diabetes Mellitus in Korea.
Kim MK, Ko SH, Kim BY, Kang ES, Noh J, Kim SK, Park SO, Hur KY, Chon S, Moon MK, Kim NH, Kim SY, Rhee SY, Lee KW, Kim JH, Rhee EJ, Chun S, Yu SH, Kim DJ, Kwon HS, Park KS; Committee of Clinical Practice Guidelines, Korean Diabetes Association. Kim MK, et al. Among authors: lee kw. Diabetes Metab J. 2019 Aug;43(4):398-406. doi: 10.4093/dmj.2019.0137. Diabetes Metab J. 2019. PMID: 31441247 Free PMC article. Review.
Acute Kidney Injury and Kidney Damage in COVID-19 Patients.
Na KR, Kim HR, Ham Y, Choi DE, Lee KW, Moon JY, Kim YS, Cheon S, Sohn KM, Kim J, Kim S, Jeong H, Jeon JW. Na KR, et al. Among authors: lee kw. J Korean Med Sci. 2020 Jul 20;35(28):e257. doi: 10.3346/jkms.2020.35.e257. J Korean Med Sci. 2020. PMID: 32686373 Free PMC article.
Immunogenic neoantigens derived from gene fusions stimulate T cell responses.
Yang W, Lee KW, Srivastava RM, Kuo F, Krishna C, Chowell D, Makarov V, Hoen D, Dalin MG, Wexler L, Ghossein R, Katabi N, Nadeem Z, Cohen MA, Tian SK, Robine N, Arora K, Geiger H, Agius P, Bouvier N, Huberman K, Vanness K, Havel JJ, Sims JS, Samstein RM, Mandal R, Tepe J, Ganly I, Ho AL, Riaz N, Wong RJ, Shukla N, Chan TA, Morris LGT. Yang W, et al. Among authors: lee kw. Nat Med. 2019 May;25(5):767-775. doi: 10.1038/s41591-019-0434-2. Epub 2019 Apr 22. Nat Med. 2019. PMID: 31011208 Free PMC article.
3,199 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page